News Daily News After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist L.A. McKeown July 13, 2015
Presentation 6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism Presenter: Francis Couturaud July 10, 2015
News Industry News The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin) July 09, 2015
News Daily News La Aprobación de la FDA de Cangrelor Amplía las Opciones Antiplaquetarias para la PCI Todd Neale June 29, 2015
News Daily News FDA Approval of Cangrelor Expands Antiplatelet Options for PCI Todd Neale June 29, 2015
News Daily News RE-VERSE AD: El Antídoto de Dabigatran, Seguro y Eficaz en un Análisis Provisional June 25, 2015
News Daily News RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis June 25, 2015
News Industry News Portola Pharmaceuticals Announces In Vivo Study Results Demonstrating Andexanet Alfa Significantly Reduced Bleeding and Reversed Anticoagulation Activity of Rivaroxaban While Four-Factor Prothrombin C June 25, 2015
News Daily News En Análisis ACCOAST Identifica los Factores asociados a Más Riesgos Hemorrágicos en el Manejo de Cuadros de SCASEST Todd Neale June 22, 2015
News Daily News ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS Todd Neale June 22, 2015
Presentation Predictors of Bleeding in ACS Patients Treated With Prasugrel Presenter: P. Widimsky June 19, 2015
News Industry News New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets June 19, 2015
News Daily News El Posible Riesgo Cardiovascular de los IBP se Mantiene en 2 Nuevos Estudios June 18, 2015
Presentation CCVVC 2015 Top 10 Advances of Interventional Cardiology 2014 Presenter: Samin K Sharma June 17, 2015